These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 20542334
1. The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity. Nakaya A, Sagawa M, Muto A, Uchida H, Ikeda Y, Kizaki M. Leuk Res; 2011 Feb; 35(2):243-9. PubMed ID: 20542334 [Abstract] [Full Text] [Related]
2. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells. Park J, Ahn KS, Bae EK, Kim BS, Kim BK, Lee YY, Yoon SS. Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088 [Abstract] [Full Text] [Related]
3. Genistein down-regulates the constitutive activation of nuclear factor-kappaB in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. He H, Chen L, Zhai M, Chen JZ. Phytother Res; 2009 Jun; 23(6):868-73. PubMed ID: 19107739 [Abstract] [Full Text] [Related]
4. Cardamonin exerts potent activity against multiple myeloma through blockade of NF-κB pathway in vitro. Qin Y, Sun CY, Lu FR, Shu XR, Yang D, Chen L, She XM, Gregg NM, Guo T, Hu Y. Leuk Res; 2012 Apr; 36(4):514-20. PubMed ID: 22226224 [Abstract] [Full Text] [Related]
5. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Jazirehi AR, Huerta-Yepez S, Cheng G, Bonavida B. Cancer Res; 2005 Jan 01; 65(1):264-76. PubMed ID: 15665303 [Abstract] [Full Text] [Related]
6. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha. Daniel LW, Civoli F, Rogers MA, Smitherman PK, Raju PA, Roederer M. Cancer Res; 1995 Nov 01; 55(21):4844-9. PubMed ID: 7585518 [Abstract] [Full Text] [Related]
7. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-kappaB in human HPV-18 E6-positive HEp-2 cells. Singh S, Bhat MK. Biochem Biophys Res Commun; 2004 May 28; 318(2):346-53. PubMed ID: 15120608 [Abstract] [Full Text] [Related]
8. Gossypol suppresses NF-kappaB activity and NF-kappaB-related gene expression in human leukemia U937 cells. Moon DO, Kim MO, Lee JD, Kim GY. Cancer Lett; 2008 Jun 18; 264(2):192-200. PubMed ID: 18314260 [Abstract] [Full Text] [Related]
9. The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma. Khong T, Sharkey J, Spencer A. Haematologica; 2008 Jun 18; 93(6):860-9. PubMed ID: 18443271 [Abstract] [Full Text] [Related]
10. Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB. Marrero MB, Bencherif M. Brain Res; 2009 Feb 23; 1256():1-7. PubMed ID: 19063868 [Abstract] [Full Text] [Related]
11. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL. Romagnoli M, Desplanques G, Maïga S, Legouill S, Dreano M, Bataille R, Barillé-Nion S. Clin Cancer Res; 2007 Oct 15; 13(20):6010-8. PubMed ID: 17947462 [Abstract] [Full Text] [Related]
12. Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3. Kim NH, Lee MY, Park SJ, Choi JS, Oh MK, Kim IS. Immunology; 2007 Dec 15; 122(4):607-14. PubMed ID: 17645497 [Abstract] [Full Text] [Related]
13. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Gupta S, Afaq F, Mukhtar H. Oncogene; 2002 May 23; 21(23):3727-38. PubMed ID: 12032841 [Abstract] [Full Text] [Related]
14. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ. Oncogene; 2002 Sep 19; 21(42):6510-9. PubMed ID: 12226754 [Abstract] [Full Text] [Related]
15. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Mol Pharmacol; 2006 Jan 19; 69(1):195-206. PubMed ID: 16219905 [Abstract] [Full Text] [Related]
16. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Olivier S, Close P, Castermans E, de Leval L, Tabruyn S, Chariot A, Malaise M, Merville MP, Bours V, Franchimont N. Mol Pharmacol; 2006 May 19; 69(5):1615-23. PubMed ID: 16497877 [Abstract] [Full Text] [Related]
17. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB. Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV. Oncogene; 2001 Nov 29; 20(55):7965-75. PubMed ID: 11753679 [Abstract] [Full Text] [Related]
18. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB. Oncogene; 2001 Nov 15; 20(52):7597-609. PubMed ID: 11753638 [Abstract] [Full Text] [Related]
19. Patrinia scabiosaefolia extract suppresses proliferation and promotes apoptosis by inhibiting the STAT3 pathway in human multiple myeloma cells. Peng J, Chen Y, Lin J, Zhuang Q, Xu W, Hong Z, Sferra TJ. Mol Med Rep; 2011 Nov 15; 4(2):313-8. PubMed ID: 21468570 [Abstract] [Full Text] [Related]
20. Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway. Kuo PL, Hsu YL, Lin TC, Tzeng WS, Chen YY, Lin CC. Cancer Lett; 2007 Apr 18; 248(2):280-91. PubMed ID: 16963181 [Abstract] [Full Text] [Related] Page: [Next] [New Search]